NEW YORK (GenomeWeb) – The Damon Runyon Cancer Research foundation said today it has awarded $4 million to fund 10 researchers engaged in molecular and cellular research aimed at treating various types of cancer.

The new grants include seven new Damon Runyon Clinical Investigators awards, which provide $450,000 to early-career physician-scientists working under mentors at major research centers, and three Continuation Grants of $300,000 to researchers who are conducting promising research or clinical trials but are nearing the end of their initial awards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.